These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis. Warnecke-Eberz U, Baldus SE, Bollschweiler E, Hoelscher AH, Metzger R. Anticancer Res; 2008 Aug; 28(3A):1525-9. PubMed ID: 18630507 [Abstract] [Full Text] [Related]
8. Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: a useful diagnostic tool for malignant pleural effusions. Liao ND, Chiang TA, Lee WY. Cancer Cytopathol; 2013 Dec; 121(12):695-702. PubMed ID: 23861325 [Abstract] [Full Text] [Related]
15. Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer. Yie SM, Lou B, Ye SR, He X, Cao M, Xie K, Ye NY, Lin R, Wu SM, Xiao HB, Gao E. Lung Cancer; 2009 Feb 15; 63(2):284-90. PubMed ID: 18606477 [Abstract] [Full Text] [Related]
18. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions. Gaspar MJ, De Miguel J, García Díaz JD, Díez M. Anticancer Res; 2008 Feb 15; 28(5B):2947-52. PubMed ID: 19031938 [Abstract] [Full Text] [Related]